The distribution and patterning of blood vessels is controlled by vascular endothelial growth factor (VEGF), which is precisely regulated throughout its life cycle. Okabe et al. show that VEGF is titrated away from the endothelium by adjacent neurons via endocytosis, regulating density and trajectory of blood vessels.
As a central regulator of angiogenesis, vascular endothelial growth factor (VEGF) is widely expressed during development, a time of significant vascular expansion. Despite this broad expression pattern, VEGF is precisely and intricately regulated at multiple levels. From alternative splicing that generates specific VEGF isoforms to interactions with extracellular matrix (ECM) that control VEGF mobility, VEGF bioavailability is fine-tuned at an extraordinary scale (Mac Gabhann and Popel, 2008) . In this issue, Okabe et al. (2014) discover another mode of regulation that contributes to this elaborate program.
In the developing retina, Okabe et al. observed that VEGF is depleted at a microscale level by engulfment and degradation in neurons neighboring the vasculature, without an apparent signaling role in these neurons. Highly localized depletion of VEGF precisely titers cytokine availability to the developing vasculature and ultimately prevents misdirected angiogenesis into the neural plane. This level of growth factor regulation has not been previously described and introduces a possible signaling-mediated ''depletion effect'' on adjacent receptor-expressing cells.
While the prevalence of growth factor depletion is yet to be determined, the significance of this mode of action must be considered in the broad context of VEGF bioavailability, which restricts access of VEGF to target receptors through multiple complex mechanisms (Figure 1 ). There are at least 14 different isoforms of VEGF with various biological activities. At one extreme, splicing of an alternative exon 8 has been found to be anti-angiogenic, whereas exclusion of exons 6 and 7 frees VEGF from the ECM, and its diffusion creates a shallow growth factor gradient. Longer VEGF isoforms bound to the ECM can be sequestered away, generating a steep gradient. When in contact with matrix-bound VEGF, endothelial cells organize unique cell-surface receptor complexes that convey distinct signaling kinetics and downstream cascades (Chen et al., 2010) . The ECM-VEGF interaction can be further modulated by plasmin and matrix metalloproteases, which cleave VEGF to promote the release of active growth factor from matrix stores (Lee et al., 2005) . Finally, local levels of soluble VEGFR1, the ''decoy receptor,'' also affect signaling by VEGF sequestration. Even upon reaching its receptor(s), cellular outcomes downstream of VEGF differ depending on the combination of receptors expressed by the cell and how readily they are endocytosed (Eichmann and Simons, 2012) . Because vasculogenesis occurs in synchrony with growth and differentiation of individual organs, one can envision a dynamic landscape of VEGF production, secretion, protease modification, and now, based on the work of Okabe et al., localized depletion. Combined, the outcome is a stereotypical vascular tree that is coordinated by the heterogeneous cellular environment, reflecting the needs of each organ.
Localized depletion of VEGF is likely to impact sprouting behavior, including location and frequency of vascular branches. Sprouting endothelial ''tip'' cells have a distinct morphology and cellular features when compared to ''stalk cells,'' a difference partially attributed to the level of VEGF exposure (Gerhardt et al., 2003) . In the developing retina, for example, VEGF at the front of the vascular plexus activates VEGFR2 on tip cells and is endocytosed as a VEGF/VEGFR2 complex at a higher rate compared to stalk cells (Nakayama et al., 2013) . High levels of VEGF signaling increase the expression of the Notch receptor Dll4, which activates Notch1 in adjacent stalk cells. Notch1 activation in the stalk cells results in a negative feedback loop reducing VEGFR2 expression, making stalk cells less receptive to extracellular VEGF cues (Hellströ m et al., 2007) . The work by Okabe et al. now modifies this model, as tip cell endocytosis may deplete VEGF that would otherwise be available to adjacent stalk cells, exacerbating predicted differences in VEGF availability. Alternatively, VEGF gradients could also exist at a subcellular level, when the efficiency of receptor endocytosis varies across the cell surface, thereby creating compartments with distinct signaling complexes dependent on receptor and ligand distribution.
VEGFR2 expressed by nonendothelial cells, such as cancer cells and hematopoietic cells, usually participates in signaling cascades that alter cellular behavior. In the central nervous system, VEGF orchestrates vessel and neuronal wiring to stimulate neuron differentiation, migration, and axon outgrowth, contributing to the formation of a functional neural network (Carmeliet et al., 2013) . Therefore, it is assumed that VEGFR2 expression in retinal neurons must be important for cell-autonomous signaling. Surprisingly, Okabe et al. show that, although VEGFR2 is phosphorylated, ablation of this gene in retinal neurons does not grossly affect the neurons' growth or differentiation. This result introduces an alternative, biologically significant function of receptor expression, which is to chelate ligand from adjacent cells. Although it is generally presumed that the major function of a receptor is to initiate signaling within the cell, we should now consider that receptors may also have an important impact on the extracellular microenvironment. As the authors speculate, VEGFR2 expression on neuroretinal cells may help to maintain a hypoxic stem cell niche by preventing excessive vascularization.
Vascular growth appears to employ a unique regulatory cascade in which VEGF is produced and then carefully whittled down to pinpoint locations. Textbook models of paracrine signaling seem to suggest systemic flooding of ligands whose actions are entirely controlled by the level of receptor. However, the high energy cost of extensive VEGF regulation as well as information from overexpression models in vivo (Miquerol et al., 2000) suggests that the rate-limiting step of VEGF signaling is actually the availability of the VEGF ligand, rather than receptors. The work presented by Okabe et al. provides an additional layer to our understanding, indicating that growth factor can also be controlled by heterotypic cells that ''steal'' VEGF from their neighboring endothelial cells. This mechanism adds to the already bursting toolkit of VEGF regulation that may be employed, in unique combinations, to fulfill the vascularization needs of each tissue. (A) Low oxygen tension activates the transcription factor HIF1 to promote vascular endothelial growth factor (VEGF) transcription. VEGF transcript is subject to alternative splicing, the products of which vary in their extracellular matrix (ECM)-binding properties. VEGF mRNA can be targeted by miRNAs that affect protein production. (B) Secreted VEGF protein is extensively modified by the extracellular environment. Shorter, soluble VEGF isoforms diffuse freely in the extracellular environment, whereas longer isoforms bind to specific extracellular matrix (ECM) proteins and are trapped to generate a steep VEGF gradient. VEGF can also be sequestered by soluble ''VEGF trap'' receptors. ECM-bound VEGF can be cleaved by extracellular proteases, releasing soluble fragments capable of diffusion and signaling, similar in action to short VEGF isoforms. (C) When VEGF successfully reaches a receptor-expressing cell, it binds to the receptor and is endocytosed and degraded. Through degradation, an area of localized VEGF depletion is created and adjacent cells are deprived of VEGF ligand. The biological activity of VEGF can also be modified by the combination of receptors expressed by the target cell, leading to different signaling cascades with various cellular outcomes.
